Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma.
Morishita A, Hozumi Y, Ishii H, Hokazono Y, Manuel Yosei Kikuchi C, Shimasaki M, Itaya M, Oura M, Kuriki K, Hishida A, Seki G.
Morishita A, et al. Among authors: itaya m.
Endocrinol Diabetes Metab Case Rep. 2023 Jan 5;2023(1):22-0269. doi: 10.1530/EDM-22-0269.
Endocrinol Diabetes Metab Case Rep. 2023.
PMID: 36602916
Free PMC article.